# Fludeoxyglucose F18

NDC: 60215-411
Generic name: Fludeoxyglucose F18
Labeler / Manufacturer: The University of Texas MD Anderson Cancer Center
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20111206

FDA application: ANDA203246

## Active ingredients

- FLUDEOXYGLUCOSE F-18: 300 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60215-411"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60215-411
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=43954e40-bb95-4275-92ab-96211b7de907